NANT Homepage
NANT Homepage About Us How You Can Help NANT Trials Contact Us

For Patients and Families

NANT: Your resource to understanding Neuroblastoma

The NANT consortium is a group of 14 children's cancer centers with strong research and treatment programs for neuroblastoma. Working closely together, they test promising new therapies for high-risk relapsed/refractory neuroblastoma that have failed standard therapy. NANT was formed to provide a group of closely collaborating investigators who are linked with laboratory programs developing novel therapies for high-risk neuroblastoma. NANT conducts clinical trials that test new drugs and new combinations of drugs against high-risk neuroblastoma. Those with promising results will then be considered for more extensive national testing.